skip to content »

Gastroenterology - Barrett's Esophagus

Houston, Texas

A BCM research lab.
Barrett's Esophagus Center
not shown on screen

Publications from members of the Barrett's program on Barrett's metaplasia, related dysplasia and cancer

  • Kramer JR, Fischbach LA, Richardson P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Velez M, Cole R, Anand B, Verstovsek G, Rugge M, Parente P, Graham, DY, El-Serag HB. Waist-to-Hip Ratio, but Not Body Mass Index, is Associated with an Increased Risk of Barrett's Esophagus in White Men. Clin Gastroenterol Hepatol. 2012 Dec 4. doi:pii: S1542-3565(12)01428-0. 10.1016/j.cgh.2012.11.028. [Epub ahead of print] PubMed PMID: 23220167.
  • El-Serag HB, Duan Z, Hinojosa-Lindsey M, Hou J, Shakhatreh M, Naik AD, Chen, GJ, Street RL Jr, Kramer JR. Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc. 2012 Oct;76(4):743-55. doi: 10.1016/j.gie.2012.06.022.PubMed PMID: 22985642.
  • Kramer JR, Arney J, Chen J, Richardson P, Duan Z, Street RL Jr,Hinojosa-Lindsey M, Naik AD, El-Serag HB. Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28;12:288. doi: 10.1186/1472-6963-12-288. PubMed PMID: 22929214; PubMed Central PMCID: PMC3508612.
  • El-Serag HB, Hollier JM, Gravitt P, Alsarraj A, Younes M. Human papillomavirus and the risk of Barrett's esophagus. Dis Esophagus. 2012 Aug 14. doi: 10.1111/j.1442-2050.2012.01392.x. [Epub ahead of print] PubMed PMID: 22891654.
  • Nordenstedt H, Younes M, El-Serag HB. Expression of androgen receptors in Barrett esophagus. J Clin Gastroenterol. 2012 Mar;46(3):251-2. doi:10.1097/MCG.0b013e318238353e. PubMed PMID: 22327304.
  • Quigley EM, Jacobson BC, Lenglinger J, Rubenstein JH, El-Serag H, Cicala M, McCallum RW, Levine MS, Gore RM. Barrett's esophagus: clinical features, obesity, and imaging. Ann N Y Acad Sci. 2011 Sep;1232:36-52. doi:10.1111/j.1749-6632.2011.06044.x. PubMed PMID: 21950806.
  • Nguyen DM, El-Serag HB, Shub M, Integlia M, Henderson L, Richardson P, Fairly K, Gilger MA. Barrett's esophagus in children and adolescents without neurodevelopmental or tracheoesophageal abnormalities: a prospective study. Gastrointest Endosc. 2011 May;73(5):875-80. doi: 10.1016/j.gie.2011.01.017. Epub 2011 Feb 26. PubMed PMID: 21354565; PubMed Central PMCID: PMC3083476.
  • El-Serag HB, Graham DY. Routine polypectomy for colorectal polyps and ablation for Barrett's esophagus are intellectually the same. Gastroenterology. 2011 Feb;140(2):386-8. doi: 10.1053/j.gastro.2010.12.019. Epub 2010 Dec 18. PubMed PMID: 21172329.
  • Nguyen DM, El-Serag HB, Shub M, Integlia M, Henderson L, Richardson P, Fairly K, Gilger MA. Barrett's esophagus in children and adolescents without neurodevelopmental or tracheoesophageal abnormalities: a prospective study. Gastrointest Endosc. 2011 May;73(5):875-80. Epub 2011 Feb 26. PubMed PMID: 21354565; PubMed Central PMCID: PMC3083476.
  • Sealock RJ, Rendon G, El-Serag HB. Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther. 2010 Sep;32(6):712-9. doi: 10.1111/j.1365-2036.2010.04411.x. Review. PubMed PMID: 20662785.
  • Nguyen DM, Schwartz J, Richardson P, El-Serag HB. Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci. 2010 Dec;55(12):3404-7. Epub 2010 Apr 16. PubMed PMID: 20397052.
  • Thakkar K, Boatright RO, Gilger MA, El-Serag HB. Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics. 2010 Apr;125(4):e925-30. Epub 2010 Mar 29. Review. PubMed PMID: 0351005.
  • Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010 Jun;138(7):2260-6. Epub 2010 Feb 23. PubMed PMID: 20188100; PubMed Central PMCID: PMC2883678.
  • El-Serag HB, Naik AD. Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology. 2009 Sep;137(3):763-5. Epub 2009 Jul 28. PubMed PMID: 19643189; PubMed Central PMCID: PMC2855541.
  • El-Serag HB, Graham DY. Routine polypectomy for colorectal polyps and ablation for Barrett's esophagus are intellectually the same. Gastroenterology. 2011 Feb;140(2):386-8. Epub 2010 Dec 18. PubMed PMID: 21172329.
  • El-Serag HB, Fitzgerald S, Richardson P. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009 Sep;104:2161-7.
  • Nguyen DM, El-Serag HB, Henderson L, Stein D, Bhattacharyya A, Sampliner R. Medication Usage and the Risk of Neoplasia in Patients with Barrett's Esophagus. Clin Gastroenterol Hepatol. 2009 Jun 9.
  • Nguyen DM, El-Serag HB, Henderson L, Stein D, Bhattacharyya A, Sampliner R. Medication Usage and the Risk of Neoplasia in Patients with Barrett's Esophagus. Clin Gastroenterol Hepatol. 2009 Jun 9.
  • El-Serag HB, Nurgalieva ZZ, Mistretta TA, Finegold MJ, Souza R, Hilsenbeck S, Shaw C, Darlington G. Gene expression in Barrett's esophagus: Laser capture versus whole tissue. Scand J Gastroenterol. 2009 Apr 24:1-9.
  • El-Serag HB, Lagergren J. Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2009 Apr;136(4):1155-7. Epub 2009 Feb 23.
  • Bull LM, White DL, Bray M, Nurgalieva Z, El-Serag HB. Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009 Feb13.
  • Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008 Mar;67(3):394-8.
  • El-Serag HB. Role of obesity in GORD-related disorders. Gut. 2008 Mar;57(3):281-4. Review.
  • El-Serag HB, Wieman M, Richardson P. The use of acid-reducing medication in veteran patients with GERD with and without Barrett's esophagus. Aliment Pharmacol Ther. 2008 Mar 21; [Epub ahead of print]
  • Standards of Practice Committee, Lichtenstein DR, Cash BD, Davila R, Baron TH, Adler DG, Anderson MA, Dominitz JA, Gan SI, Harrison ME 3rd, Ikenberry SO, Qureshi WA, Rajan E, Shen B, Zuckerman MJ, Fanelli RD, VanGuilder T. Role of endoscopy in the management of GERD. Gastrointest Endosc. 2007 Aug;66(2):219-24.
  • Qureshi NA, Hallissey MT, Fielding JW. Outcome of index upper gastrointestinal endoscopy in patients presenting with dysphagia in a tertiary care hospital-A 10 years review. BMC Gastroenterol. 2007 Nov 22;7:43.
  • Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007 Mar;150(3):262-7, 267.e1.
  • Nurgalieva Z, Lowrey A, El-Serag HB. The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review. Dig Dis Sci. 2007 May;52(5):1345-54.
  • El-Serag HB, Nurgalieva Z, Souza RF, Shaw C, Darlington G. Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointest Endosc. 2006 Jul;64(1):17-26.
  • El-Serag HB. Temporal trends in new and recurrent esophageal strictures in Department of Veterans Affairs. Am J Gastroenterol. 2006 Aug;101(8):1727-33.
  • El-Serag HB, Gilger MA, Shub MD, Richardson P, Bancroft J. The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc. 2006 Nov;64(5):671-5.
  • Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199-211.
  • El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005 Oct;100(10):2151-6.
  • Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE. The association of body mass index with Barrett's esophagus. Aliment Pharmacol Ther. 2005 Nov 15;22(10):1005-10.
  • Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004 Nov;99(11):2210-6.
  • El-Serag HB, Garewel H, Kuebeler M, Sampliner RE. Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. Clin Gastroenterol Hepatol. 2004 Apr;2(4):296-300.
  • El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, Rabeneck L. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun;126(7):1692-9.
  • El-Serag HB, Aguirre T, Kuebeler M, Sampliner RE. The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. Aliment Pharmacol Ther. 2004 Jun 15;19(12):1255-60.
  • El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2004 Oct; 99(10):1877-83. PMID: 15447744 [PubMed - indexed for MEDLINE]
  • El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2002 Jun;31(2):421-40, viii. Review.
  • El-Serag HB, Bailey NR, Gilger M, Rabeneck L. Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol. 2002 Jul;97(7):1635-9.
  • Qureshi WA, El-Zimaity H, Green LK, Graham DY. Screening for Barrett's esophagus: searching for a new technique. Am J Gastroenterol. 2002 Jun;97(6):1565-6.
  • El-Serag HB. Segment length and risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000 Nov 7;133(9):747-8.
  • El-Serag HB, Sonnenberg A, Jamal MM, Kunkel D, Crooks L, Feddersen RM. Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol. 1999 Mar;94(3):622-7.
  • El-Serag HB. Barrett's esophagus, hiatal hernia, and logistic regression analysis. Am J Gastroenterol. 1999 Dec;94(12):3395-6.

E-mail this page to a friend